Hardware/Software Validation Issues Key For Successful PDPs, Exec Says
This article was originally published in The Gray Sheet
Validation and verification of hardware and software and their role in manufacturing processes will be one of the toughest hurdles for device firms seeking to clear products through the FDA's Product Development Protocol process, according to U.S. Surgical Corp.' s VP-Quality and Regulatory Affairs Louis Mazzarese.
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.